In the immunohistochemical study, the exuberant vascular proliferation characteristically observed in AITL may be better evidenced by the endothelial markers CD31 and CD34, as well as the expanded FDC meshwork, evidenced by staining for CD21, CD23 and CD35 antigens. The gene discussed is CR2; the disease is angioimmunoblastic T-cell lymphoma.